Digital physiotherapy platform FlexifyMe has raised ₹20 crore (approximately $2.4 million) in a pre-Series A round led by IvyCap Ventures, with participation from Signal Ventures and its existing backers. The healthtech startup, which gained national attention after featuring on Shark Tank India Season 3, said the new capital will be directed towards expanding its hybrid care model, opening advanced posture and gait analysis labs, and deepening clinical research partnerships.
Founded in 2021 by Manjeet Singh and Amit Bhayani, FlexifyMe combines artificial intelligence with licensed physiotherapy to treat chronic musculoskeletal conditions such as lower back, neck, and shoulder pain. Its proprietary system analyzes posture and motion to detect weaknesses and guide patients toward corrective treatment. Unlike traditional symptom-led care, the platform claims to deliver measurable, data-backed interventions.
The company offers one-on-one live physiotherapy sessions, curated video-based exercise programs, and yoga routines through subscription packages. It also partners with enterprises, insurers, and healthcare providers to integrate its solutions into larger wellness ecosystems.
“Our goal is to make recovery from chronic pain scientific and measurable. By blending AI insights with qualified physiotherapists, we can help patients avoid unnecessary surgeries and return to active living faster. This funding will allow us to build more labs, strengthen clinical validation, and scale our services across India,” said Manjeet Singh, co-founder of FlexifyMe.
The startup had earlier raised $1 million in a seed round led by Flipkart Ventures. Its Shark Tank India pitch attracted Emcure Pharmaceuticals’ executive director Namita Thapar, who invested in the company during Season 3.
India’s physiotherapy and rehabilitation market is expected to grow rapidly as lifestyle-related chronic pain conditions rise. FlexifyMe’s bet is that a tech-first, hybrid approach can capture this demand at scale.
